Literature DB >> 27655534

[Current research status of drug therapy for apnea of prematurity].

Chao Chen1, Xian-Xiao Shu, Xiao-Yan Yang, Jing Shi, Jun Tang, De-Zhi Mu.   

Abstract

OBJECTIVE: To investigate the current status of studies on drug therapy for apnea of prematurity (AOP) in the past decade in China and abroad, and to describe the research trends in the field.
METHODS: CNKI and MEDLINE were searched with the key words "apnea of prematurity" and "treatment" for articles published in the past decade (January 2006 to December 2015). The articles were screened and the key words were extracted to establish the co-occurrence matrix. Ucinet 6.2 was used to plot the knowledge map.
RESULTS: A total of 26 Chinese key words and 20 English key words were included. Those in the center of the co-existent knowledge map of Chinses keywords were "preterm infants", "apnea", "primary apnea", "naloxone" and "aminophylline"; while "apnea", "preterm infants" and "caffeine" located in the central place of the co-existent knowledge map of English keywords.
CONCLUSIONS: Methylxanthines are still the major drugs for AOP; however, aminophylline is mainly used in China, while caffeine is mainly used in foreign countries. Other drugs such as naltrexone are also used in the clinical treatment of AOP.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655534      PMCID: PMC7389980     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  16 in total

Review 1.  A new look at the respiratory stimulant doxapram.

Authors:  C Spencer Yost
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 2.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

3.  Apnea of Prematurity.

Authors:  Eric C Eichenwald
Journal:  Pediatrics       Date:  2015-12-01       Impact factor: 7.124

Review 4.  Methylxanthine treatment for apnoea in preterm infants.

Authors:  David J Henderson-Smart; Antonio G De Paoli
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 5.  Clinical pharmacology of theophylline in preterm infants: effects, metabolism and pharmacokinetics.

Authors:  Gian Maria Pacifici
Journal:  Curr Pediatr Rev       Date:  2014

Review 6.  Doxapram treatment for apnea in preterm infants.

Authors:  D Henderson-Smart; P Steer
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

7.  Long-term effects of caffeine therapy for apnea of prematurity.

Authors:  Barbara Schmidt; Robin S Roberts; Peter Davis; Lex W Doyle; Keith J Barrington; Arne Ohlsson; Alfonso Solimano; Win Tin
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

8.  [Investigation of pharmacokinetics and pharmacodynamics of different doses of aminophylline in very low birth weight infants].

Authors:  Xiao-Yan Yang; Jing Zhao; Jing Shi; Jin-Lin Wu; Da-Peng Chen; Jun Tang; Ying Xiong; De-Zhi Mu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2015-11

9.  Pharmacokinetic aspects of caffeine in premature infants with apnoea.

Authors:  R Gorodischer; M Karplus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Doxapram use for apnoea of prematurity in neonatal intensive care.

Authors:  S A Prins; S J A Pans; M M van Weissenbruch; F J Walther; S H P Simons
Journal:  Int J Pediatr       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.